2 Million Hours of Scientific Research:
Discovering Therapies from the
Land of Buddha's Enlightenment
and Mastering the Art of Healing.
exRNA Therapeutics
Pioneers in RNA-Based Innovations!!
At exRNA Therapeutics Limited, groundbreaking science and compassion converge to usher in a new era of precision of drug development. Inspired by the intricate functionality of tRNA fragments (tRF), we harness the power of RNA-based therapies to address the unmet needs of patients battling rare diseases, Neurological diseases and autoimmune diseases.
Redefining realm of medicine through ASO Formulations
Antisense oligonucleotides (ASOs) are short, synthetic pieces of nucleic acids designed to specifically bind to the RNA molecules within cells. This binding can alter the expression of genes, offering a targeted approach to treat genetic disorders, including neurological diseases. Our novel ASO formulations, G1 represent a cutting-edge approach in the unmet needs of patients battling rare diseases, Neurological diseases and autoimmune diseases.
Embracing Rare
At exRNA, we understand the complexities of
rare diseases and the unique needs of those affected.
With a focus on DMD and Psoriasis,
we passionately embrace the rare,
cultivating solutions and providing a beacon of hope
for individuals and families navigating these challenging conditions.
Non-coding RNA regulation as Future of Therapy
Non-coding RNAs (ncRNAs) regulate gene expression and are key in disease development, influencing cell growth and apoptosis. Dysregulated ncRNAs contribute to conditions like autoimmune disorders and neurological disorders. Targeting ncRNAs offers a promising therapeutic approach by correcting abnormal gene expression, providing precise and effective treatments for diseases lacking targeted therapies
Breakthrough Therapeutic Solutions
Autism Spectrum Disorder (ASD)
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by challenges in social interaction, communication, and repetitive behaviors. The severity and symptoms of ASD can vary widely among individuals. It typically appears in early childhood and affects the individual's ability to function socially, academically, and in other areas of life.
Duchenne muscular dystrophy (DMD)
Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder causing progressive muscle weakness and degeneration due to mutations in the DMD gene, which leads to a lack of dystrophin protein. It mainly affects boys, with symptoms like delayed walking and difficulty running starting between ages 2 and 5.
Psoriasis
Psoriasis is a chronic autoimmune skin condition causing rapid skin cell growth, leading to red, scaly patches. Commonly affected areas include the scalp, elbows, knees, and lower back. It has genetic, immune, and environmental triggers. Treatments include topical medications, phototherapy, and systemic drugs.
Collaborations
Banaras Hindu University (BHU)
University Of Hyderabad (UOH)
Central University Of South Bihar (CUSB)
Centre For Cellular and Molecular Platforms(C-CAMP)
Certifications
2196/PO/Rc/S/2022/CPCSEA
(TU/IV-RD/4586/2024)
